In the US, Aptar Digital Health, a provider of digital health solutions, has announced its acquisition of Healint, a Singapore-based company specialising in multimodal health and the generation of real-world evidence for improving treatment outcomes and expediting clinical trials. According to a press release, Aptar is hoping that the acquisition […]
Tag: AI
Singapore-based Qritive announces collaboration with diagnostic centres and hospitals in India
Singapore-based AI solution provider Qritive has announced an upcoming collaboration with three diagnostic centres and hospitals in India: Metropolis Healthcare, the Rajiv Gandhi Cancer Institute and CŌRE Diagnostics. The collaboration will see Qritive’s AI technology integrated into pathology workflows, in a move which the company hopes will help to improve […]
European Parliament adopts act designed to govern use of AI whilst boosting innovation
The European Parliament has adopted the Artificial Intelligence Act, marking a “landmark” in the regulation of AI in Europe, whilst “boosting innovation and establishing Europe as a leader in the field”. The new rules ban certain AI applications that are deemed to threaten citizen’s rights, as well as establishing obligations […]
South Korean med tech company Lunit to acquire AI supplier Volpara
Lunit, a deep learning-based medical AI company based in South Korea, has announced the signing of a Scheme Implementation Agreement to acquire Volpara Health Technologies, a company focused on AI-enabled software for early detection of cancer, in a move which would bring together AI expertise, data and capabilities. The agreement […]
German institute shares projects on AI in public health
Germany’s Robert Koch Institute has shared a number of PhD projects for its doctoral programme on AI in Public Health, including AI-based spatial mapping of microbial pathogens; AI-supported annotation of horizontal gene transfer in monitoring antimicrobial resistance; and ML-assisted rapid detection of pathogens using nanopore sequencing. PhD students at the […]
International collaboration sees launch of HealthX, a new digital health platform for insurers
An international collaboration between Foyer Global Health, an international health insurance provider, and Galytix, a provider of a generative AI platform for financial institutions, has seen the launch of a new digital health platform for insurers. The platform, HealthX, uses generative AI to combine structured and unstructured data, providing insights […]
New partnership in France to drive innovations in clinical research and AI
A new partnership in France has been announced between global advisory and clinical research firm Alira Health and Sancare, a company specialising in harnessing the potential of hospital data through AI. The partnership will focus on the launch of a platform of “deep hospital electronic medical record data linked with […]
Interview: Sarah Jabbour, University of Michigan, on AI in healthcare
We recently caught up with Sarah Jabbour, PhD candidate in Computer Science and Engineering at the University of Michigan, to talk about her research on the challenges and opportunities of machine learning, human-AI interaction, and models for diagnosis in healthcare. We asked Sarah to introduce herself, and to share with […]
European PAIR project launches interactive tools to support point-of-care diagnostics and epidemiological modelling
A new EU-funded five-year project, “PAIR”, has been launched in the hopes of improving point-of-care (POC) diagnostics and epidemiological modelling, bringing together 20 partners from seven countries with the aim of helping Europe to develop expertise and capabilities in this area based on artificial intelligence and machine learning. Utilising the […]
Finnish health tech company CardioSignal raises $10m for heart disease detection tech
Finnish health tech company CardioSignal has announced that it has raised $10 million in Series A funding for their tech to promote early detection of heart diseases, with the investment intended to help scale the solution and pursue further clinical validation. The company’s patented technology uses one clinical modality without […]